SUBMIT YOUR ABSTRACT FOR ASRM 2026
ASRM CPL’s new report analyzes the Trump administration’s IVF initiative—examining drug‑pricing, employer fertility benefits, access, equity, and policy implications.
Federal funding cuts to NIH, CDC, and FDA threaten reproductive health research, patient safety, and access to care, warns new ASRM policy report.
IVF births in the U.S. surpass 100,000 in 2024, highlighting rising demand, improved safety, and advances in fertility care and reproductive medicine.
HOPE Act reintroduced to mandate nationwide insurance coverage for infertility care, expanding access to IVF, fertility preservation, and essential treatments.
Study finds PFAS “forever chemicals” may harm fertility, raise preeclampsia risk, and increase preterm birth, highlighting urgent reproductive health concerns.
ASRM has responded to the latest announcement about TrumpRx and its impact on IVF treatments.
The Impact of Federal Funding Cuts on Patients, Providers, and the Field of Reproductive Medicine.
Explore how carrier screening supports informed family planning—panel types, timing, risks, and how ASRM-guided care empowers reproductive choices.
Experts reveal how BMI affects fertility and pregnancy, with tips on weight, treatment options, and personalized preconception planning.
ASRM's updated infertility definition became a catalyst for regulatory action internationally and yielded new hope for growing families on the other side of
Displaying 1141 to 1150 of 1669 records
